Alpha Tau Medical Ltd (DRTS) Price to Earnings Ratio

Corporate emblem and logo of Alpha Tau (DRTS)

This daily price chart for Alpha Tau Medical Ltd. (DRTS) reflects a P/E ratio of -13.40. Alpha Tau Medical Ltd. generates revenue by supplying alpha-therapy systems to global oncology centers to combat hard-to-treat tumors. Effective Israeli management ensures patent protection and research transparency. Simultaneously, the company is implementing robotic complexes that automatically accelerate genetic sequence analysis and the search for new molecules.

Alpha Tau Medical Ltd (DRTS): Price to Earnings Ratio from 04/28/2023 to 11/14/2026

Analytical breakdowns for Alpha Tau Medical Ltd.

- stock quotes and analyst forecast:
Price Chart Alpha Tau Medical Ltd|DRTS - Price Target Chart
- market capitalization details:
Market Value Alpha Tau Medical Ltd|DRTS - Enterprise Value
- book capitalization information:
Book Value per Share Alpha Tau Medical|DRTS - Company Book Value|Capitalization to Book Value Ratio alphatau.com|DRTS - Company Total Assets
- debt and solvency information:
Debt to Capital Alpha Tau Medical Ltd.|DRTS - Long-Term Debt to Equity|Current Liabilities to Capital Alpha Tau Medical|DRTS - Company Total Debt|Debts to Book Capitalization Alpha Tau|DRTS - Company Long-Term Debt|Short-Term Debt Volume Alpha Tau Medical|Intermediate Coverage Ratio alphatau.com
- net income and valuation ratios data:
DRTS - Company Net Income|Expected Net Profit Alpha Tau Medical Ltd.|DRTS - Price to Earnings Ratio|Price to Future Earnings Ratio Alpha Tau|DRTS - PEG Multiple|Enterprise Value to EBITDA Ratio Alpha Tau|DRTS - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Alpha Tau Medical|DRTS - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months alphatau.com|DRTS - Earnings per share growth in current year|Expected net earnings per share growth next year Alpha Tau Medical Ltd.
- sales volume and revenue indicators:
DRTS - Revenue and Sales Volume|Company Sales Forecast Alpha Tau|DRTS - Market Cap to Revenue|Market Cap to Future Revenue Ratio Alpha Tau Medical Ltd
General company analysis:DRTS, Alpha Tau Medical Ltd
Original product of Alpha Tau Medical

Alpha Tau Medical Ltd. (DRTS) monetizes its patented pinpoint radiotherapy technology through the regular supply of emitters to clinics. The P/E ratio determines the cost of one dollar of net income, reflecting the market price for current business efficiency. An analysis of the price-to-earnings valuation allows for the identification of overpayment for future growth or the undervaluation of operational successes. The indicator's dynamics demonstrate the level of investor confidence in the long-term capital sustainability of the issuer.

Analysis of competing companies

Price to Earnings Ratio NVCR|Price to Earnings Ratio Fortress (FBIO)|Price to Earnings Ratio ACRV (Acrivon)|P/E Multiple ALLR (Allarity Therapeutics Inc.)